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CORRESPONDENCE
Letters to the Editor
Peak Oxygen
Consumption and Heart
Failure Prognosis in Women
There is nothing new except what has been forgotten
Marie Antoinette (1)
We read with interest the recent study by Elmariah et al. (2) as well
as the intriguing editorial by Feldman (3) regarding potential
genetic factors to explain gender differences in heart failure (HF)
prognosis. Elmariah et al. (2) demonstrated that peak oxygen
consumption (VO2) was significantly lower in women with HF
than in men and that this cardiopulmonary variable did not predict
HF prognosis or the need for cardiac transplantation as well in
women as it did in men. We firmly agree with this assessment and
have made this point (although in a smaller number of women) in
several publications during the past decade, sources not cited in
their excellent study (4–9).
Although our initial observations were made nearly 10 years ago
in a small sampling of women with HF (4), we subsequently sorted
this issue out in more detail by noting that higher body fat is an
independent predictor of better HF prognosis, which may partly
explain the well-recognized “obesity paradox” (7,8,10–13). Be-
cause women typically have considerably higher levels of percent
body fat and, for practical purposes, fat weight is not aerobically
active, it would make sense that VO2 corrected for total body
weight would be lower in groups of patients with higher body fat
(e.g., women and more obese patients) (5–9,11,13,14). However, if
one adjusts peak VO2 for lean body mass as opposed to total
weight, both genders and obese versus lean patients have more
similar functional capacities, and this assessment allows for more
accurate determination of HF prognosis (5,6,8,9,13). We have
most recently demonstrated that peak O2 pulse (peak VO2/peak
heart rate) adjusted for lean body mass was even slightly superior to
peak VO2 corrected for lean body mass for HF prognostication (6).
Therefore, we agree with these investigators that this evidence
must be considered when cardiopulmonary metabolic parameters
are used for prognostic stratification of women with HF (4–6,9).
Furthermore, a simple and very inexpensive determination of
percent body fat by the sum of the skin-fold method (or using
more sophisticated and expensive techniques such as dexa scanning
or underwater weighing) and correcting VO2 or O2 pulse for lean as
opposed to total weight should substantially improve the accuracy
of cardiopulmonary testing for HF stratification, particularly in
women and in other groups of patients with higher percent body
fat. Finally, although in some situations complex mechanisms are
involved, we believe that this is an example of where one may often
reach for complex explanations for findings when in fact the simple
explanation may be staring us in the face!
As Edward R. Murrow noted: “The obscure we see eventually.
The completely obvious, it seems, takes longer” (15).
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Reply
We appreciate the letter by Dr. Lavie and colleagues in
reference to our report on the effects of gender on the
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